RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,337,123 | +4.2% | 407,290 | -25.0% | 0.03% | -6.5% |
Q2 2023 | $8,957,533 | -24.4% | 543,210 | -18.2% | 0.03% | -26.2% |
Q1 2023 | $11,846,224 | +87662.8% | 664,026 | +43.3% | 0.04% | -14.3% |
Q4 2022 | $13,498 | -99.9% | 463,516 | -1.5% | 0.05% | +11.4% |
Q3 2022 | $11,525,000 | +302.7% | 470,410 | -31.8% | 0.04% | +300.0% |
Q2 2022 | $2,862,000 | -64.8% | 689,720 | -2.3% | 0.01% | -52.2% |
Q1 2022 | $8,132,000 | +19.0% | 705,920 | +3.1% | 0.02% | +15.0% |
Q4 2021 | $6,834,000 | +4.2% | 684,746 | +36.3% | 0.02% | -4.8% |
Q3 2021 | $6,560,000 | +135.1% | 502,270 | +252.5% | 0.02% | +133.3% |
Q2 2021 | $2,790,000 | – | 142,472 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $9,074,000 | 1.96% |
NEA Management Company, LLC | 4,912,306 | $49,025,000 | 0.99% |
RA Capital Management | 4,871,067 | $48,613,000 | 0.86% |
Samsara BioCapital, LLC | 345,293 | $3,446,000 | 0.67% |
Endurant Capital Management LP | 197,462 | $1,971,000 | 0.48% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,867,467 | $18,637,000 | 0.39% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $274,000 | 0.20% |
Baker Brothers Advisors | 3,863,239 | $38,555,000 | 0.19% |
Rock Springs Capital Management LP | 627,180 | $6,259,000 | 0.14% |
Aquatic Capital Management LLC | 4,000 | $40,000 | 0.08% |